Liver transplantation for pediatric patients: a review and update

R E Kleinman1

  • 1Combined Program in Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.

Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi [Journal]. Zhonghua Minguo Xiao Er Ke Yi Xue Hui
|March 1, 1996
PubMed

Insights

Pediatric liver transplantation has advanced significantly, improving patient selection and outcomes. Future innovations in gene therapy and cell grafts may reduce the need for transplants.

Area of Science:

  • Hepatology
  • Pediatric Surgery
  • Immunology

Background:

  • Liver transplantation for pediatric patients has evolved over 25 years.
  • Improved understanding of liver disease and preservation solutions allows for better timing of transplants.
  • Advances in immunosuppression and immune tolerance are crucial for transplant success.

Purpose of the Study:

  • To review the progress and future directions in pediatric liver transplantation.
  • To highlight advancements in surgical techniques, immunosuppression, and emerging therapies.
  • To discuss the evolving criteria for patient selection and management.

Main Methods:

  • Review of historical data and recent advancements in pediatric liver transplantation.
  • Analysis of the impact of new preservation solutions and immunosuppressive strategies.
  • Exploration of novel therapeutic approaches like gene transfer and cell-based therapies.

Main Results:

  • Significant improvements in pediatric liver transplant outcomes have been observed.
  • Elective transplant timing is now possible due to advanced preservation solutions.
  • Enhanced immunosuppression and immune tolerance protocols minimize rejection and infection risks.

Conclusions:

  • Pediatric liver transplantation has seen remarkable progress, enhancing patient survival and quality of life.
  • Ongoing research in molecular biology, gene therapy, and cell grafts promises to further refine and potentially reduce the need for traditional liver transplantation in select pediatric cases.
  • Continued advancements in immunosuppression and understanding immune tolerance are key to optimizing long-term graft function and patient health.